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Abstract 
Whole-arm chromosome translocations involving 
the long arm of chromosome 1 are nonrandom 
aberrations in hematologic malignancies that 
commonly involve acrocentric chromosomes. 
Among  them, unbalanced whole-arm translocations 
between chromosomes 1 and 13 are relatively rare 
cytogenetic aberrations and has been reported in 
both lymphoid and myeloid neoplasms. 
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Clinics and pathology 
Disease 
Myeloproliferative disorders, multiple myeloma and 
lymphoid malignancies 
Phenotype/cell stem origin 
Reported in diverse hematologic disorders 
Etiology 
Different factors like constitutional fragility of the 
1q heterochromatin, cytotoxic drugs, ionizing 
radiation and/or oncogenic viruses are suspected to 
be implicated in the origin of 1q rearrangements. 
Epidemiology 
Reported at least in 20 cases (Table 1); median age 
52 years (range 20-86), balanced sex ratio  
(11M/9F). Found in: chronic myeloproliferative 
disorders (8 of the 20 available cases): polycythemic 
myelofibrosis (PPMF) in 1 case, essential 
trombocytopenia (ET) in 1 case, chronic myeloid 
leukemia (CML) in 1 case; myelodysplastic 
syndromes (MDS) in transformation in 3 patients as 
well as in acute myeloid leukaemia (2 patients), 
multiple myeloma (4 patients) and in lymphoid 
malignancies (8 patients). 
Evolution 
Whether karyotypic changes associated with extra 
copies of 1q are primary events or they are induced 
during disease evolution as a side effect of cytotoxic 
treatments is unclear.  
May be found as a sole anomaly in chronic 
myeloproliferative disorders (Andrieux et al, 2003; 
Tanaka et al, 2006), indicating that der(1;13) might 
be a primary change in myeloid disorders.  
Occurred as part of complex karyotypes in multiple 
myeloma and lymphoproliferative malignancies, 
suggesting that 1q abnormalities may be secondary 
events in these diseases representing clonal 
evolution associated with natural disease evolution. 
Prognosis 
It is likely that the prognosis depends on the patient 
diagnosis in myeloid malignancies (chronic disease 
versus acute leukemia).  
Prognosis in multiple myeloma and lymphoid 
malignancies is uncertain. 
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G-banded partial karyogram of bone marrow cells showing the der(1;13)(q10;q10) chromosome. Fluorescence in situ 
hybridization with Vysis (Abbott Molecular) LSI 1p36 (red)/ 1q25 (green) and LSI Rb (red) probes showing an extra green signal 
located on 1q25 on the der(1;13)(q10;q10) chromosome (arrow) 
 
Cytogenetics 
Cytogenetics morphological 
Presents as -13, + der(1;13)(q10;q10); less 
frequently as der(1;13)(p10;q10) or 
der(1;13)(q10;p10) 
Genes involved and 
proteins 
Genes involved are unknown; the region 1q21-1q32 
has been suggested to contain oncogenes that are 
involved in disease pathogenesis 
Result of the chromosomal 
anomaly 
Fusion protein 
Oncogenesis 
Acquired whole-arm chromosome translocations 
with involvement of the 1q heterochromatin are 
accompanied by genomic imbalances in hematologic 
malignancies. The chromosome 1 pericentromeric 
heterochromatin is a notoriously an unstable 
chromosomal region that is involved in diverse 
chromosomal rearrangements leading to gene 
dosage abnormalities.  
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Abbreviations:  Ref., reference; PPMF, postpolycythemic myelofibrosis; f, female; m, male; MDS, myelodysplastic syndrome; FA, 
Fanconi anemia; CML, chronic myeloid leukemia; AML, acute myeloid leukemia; ET, essential thrombocythemia; MM, multiple 
myeloma; DLBCL, diffuse large B-cell lymphoma. Chromosome anomalies detected in the lymph node. Reference : 1. Swolin et 
al., 1983; 2. Fleischman et al., 1989; 3. Horiike et al., 1994; 4. Hashimoto et al., 1995; 5. Sawyer et al., 1995; 6. Sawyer et al., 
1998; 7. Lindvall et al., 2001; 8. Andrieux et al., 2003; 9. Gascoyne et al., 2003; 10. Horsman et al., 2003; 11. Lestou et al., 2003; 
12. Tanaka et al., 2006; 13. Adeyinka et al., 2007; 14. Mohamed et al., 2007; 15. Johnson et al., 2008; 16. Bajaj et al., 2011; 17. 
Flach et al., 2011; 18. Quentin et al., 2011; 19. Sawyer et al., 2014 
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The acquisition of the long arm of chromosome 1 
results in trisomy of the whole-arm of chromosome 
1 and partial monosomy of the involved 
chromosome. Duplication of the chromosome 
segment of 1q11-1q32 is commonly observed in 
these rearrangements, indicating that certain 
chromosome 1 regions, especially 1q21-1q32 might 
harbor pathogenetically relevant oncogenes. The 
unbalanced nature of the der(1;13)(q10;q10) 
indicates that the gain of 1q may play an important 
role in neoplastic transformation and/or disease 
progression. Although a der(1;13)(q10;q10) 
translocation has been reported in various neoplastic 
conditions, such as multiple myeloma and 
lymphoma, this translocation is also observed in both 
chronic and acute myeloid disorders. The 
observation of this anomaly was closely associated 
with leukemic transformation in myeloid 
malignancies suggesting that der(1;13)(q10;q10) 
might be a rare but nonrandom primary change in 
these disorders preceding or accompanying disease 
evolution. 
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